Approach to Chd full details for md exams 15marks from nelson and ur data

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from multiple textbooks. Let me compile the full 15-mark MD exam answer on Approach to Congenital Heart Disease.

APPROACH TO CONGENITAL HEART DISEASE (CHD)

For MD Examinations - 15 Marks


1. DEFINITION & INCIDENCE

Congenital heart diseases are structural/functional abnormalities of the heart or great vessels present at birth. They account for 20-30% of all birth defects and affect nearly 1% of live newborns (~40,000 infants/year in the USA). They are more common in premature infants and stillborns (~25% of stillborns). Incidence is higher with assisted reproductive techniques (IVF).
  • Robbins & Kumar Basic Pathology, p. 347
  • Schwartz's Principles of Surgery, p. 814

2. ETIOLOGY & RISK FACTORS

Faulty embryogenesis during gestational weeks 3-8 (when major cardiovascular structures form) is the primary cause. The etiology is unknown in ~90% of cases.
Risk factors:
CategoryExamples
Genetic/chromosomalTrisomy 21 (Down's - AV canal, VSD), Trisomy 18, Trisomy 13, Turner syndrome (Coarctation of aorta)
Maternal conditionsDiabetes, hypertension, obesity, phenylketonuria, thyroid disorders, SLE
Maternal drugsPhenytoin, retinoic acid (Vitamin A), lithium (Ebstein anomaly), alcohol
Maternal infectionsRubella (PDA, pulmonary stenosis), CMV, coxsackie virus, parvovirus B19, toxoplasmosis
PrematurityEspecially PDA
Assisted reproductionIVF
Family historyMultifactorial inheritance

3. CLASSIFICATION

The standard clinical classification is based on presence or absence of cyanosis at presentation:
CHD
├── ACYANOTIC (L→R shunt initially, NO early cyanosis)
│   ├── WITH INCREASED PULMONARY BLOOD FLOW (shunts)
│   │   ├── VSD (most common CHD, 42%)
│   │   ├── ASD (10%)
│   │   ├── PDA (7%)
│   │   └── AVSD / AV canal defect (4%)
│   └── WITH NORMAL/DECREASED PULMONARY BLOOD FLOW (obstructive)
│       ├── Pulmonary stenosis (8%)
│       ├── Aortic stenosis (4%)
│       └── Coarctation of aorta (5%)
│
└── CYANOTIC (R→L shunt, EARLY cyanosis)
    ├── WITH INCREASED PULMONARY BLOOD FLOW
    │   ├── TGA - Transposition of Great Arteries (4%)
    │   ├── Truncus arteriosus (1%)
    │   └── TAPVC - Total Anomalous Pulmonary Venous Connection (1%)
    └── WITH DECREASED PULMONARY BLOOD FLOW
        ├── Tetralogy of Fallot (most common CYANOTIC CHD, 5%)
        ├── Tricuspid atresia (1%)
        └── Pulmonary atresia
Frequency by defect (per million live births, Robbins):
MalformationFrequency (%)
VSD42%
ASD10%
Pulmonary stenosis8%
PDA7%
Tetralogy of Fallot5%
Coarctation of aorta5%
AVSD4%
Aortic stenosis4%
TGA4%
Others~9%

4. PATHOPHYSIOLOGY OF SHUNTS

Left-to-Right Shunts (Acyanotic)

  • Increased blood flow into pulmonary circulation
  • No early cyanosis
  • Prolonged exposure leads to pulmonary hypertension and increased pulmonary vascular resistance (PVR)
  • Eventually causes shunt reversal (R→L) = Eisenmenger Syndrome - marked by late-onset cyanosis
  • Once significant pulmonary hypertension develops, the defect is considered irreversible - this is why early surgical repair is critical

Right-to-Left Shunts (Cyanotic)

  • Pulmonary circulation bypassed
  • Poorly oxygenated blood enters systemic circulation → cyanosis
  • Leads to hypoxemia, polycythemia, clubbing
  • Robbins & Kumar Basic Pathology, p. 348

5. INDIVIDUAL LESIONS - DETAILED APPROACH

A. VENTRICULAR SEPTAL DEFECT (VSD) - Most Common CHD (42%)

Types (by location):
  1. Perimembranous (paramembranous) - Most common type requiring surgery (~80%) - involves membranous septum
  2. AV canal (inlet) - Beneath tricuspid valve, limited by tricuspid annulus
  3. Supracristal (outlet) - Within conal septum, limited by pulmonary valve
  4. Muscular - Most common overall, surrounded by muscle; "Swiss-cheese" = multiple holes
Pathophysiology:
  • Small (restrictive) VSD: little shunting, often self-close
  • Large (nonrestrictive) VSD: diameter ≥ aortic annulus, free L→R flow, equalization of RV/LV pressure → pulmonary hypertension → Eisenmenger's
Clinical features:
  • Pansystolic murmur at lower left sternal border
  • Loud murmur = small VSD ("maladie de Roger")
  • Large VSD: recurrent chest infections, failure to thrive, tachypnea
Diagnosis: Echo (2D + color Doppler), CXR (cardiomegaly, increased pulmonary vascularity), ECG (LVH/biventricular hypertrophy)
Treatment:
  • Small: watchful waiting (many close spontaneously by age 2)
  • Moderate-Large: surgical patch closure or transcatheter device closure
  • Indication: Qp:Qs > 2:1, recurrent infections, failure to thrive
  • Contraindication: PVR >12 Wood units (inoperable - Eisenmenger's)
  • Schwartz's Principles of Surgery, p. 814

B. ATRIAL SEPTAL DEFECT (ASD) - 10%

Types:
  1. Ostium secundum - Most common (75%) - in fossa ovalis region
  2. Ostium primum - Near AV valves, associated with cleft mitral valve
  3. Sinus venosus - Near SVC/IVC entry; associated with anomalous pulmonary venous drainage
  4. Coronary sinus type - Rare
Note: Patent Foramen Ovale (PFO) ≠ ASD. PFO persists in 20% of adults; not a true defect.
Pathophysiology: L→R shunt → increased RV and pulmonary volumes (not pressure initially) → RV volume overload
Clinical features:
  • Often asymptomatic in childhood
  • Wide fixed splitting of S2 (hallmark)
  • Ejection systolic murmur in pulmonary area (due to increased flow, not ASD itself)
  • Mild diastolic rumble at tricuspid area
Diagnosis: Echo; CXR shows prominent pulmonary arteries, right heart enlargement; ECG shows rSR' in V1 (incomplete RBBB), RAD for secundum
Complications: Atrial arrhythmias, paradoxical embolism, stroke, pulmonary hypertension
Treatment:
  • Secundum: transcatheter device closure (Amplatzer)
  • Primum/sinus venosus: surgical repair
  • Timing: elective repair 2-4 years (before school)
  • Robbins & Kumar Basic Pathology, p. 348-349

C. PATENT DUCTUS ARTERIOSUS (PDA) - 7%

Physiology: Ductus arteriosus (connects aorta to pulmonary artery) normally closes within 24-48h of birth due to rise in PO2. Failure to close = PDA.
Common in: Prematurity (due to immature smooth muscle), congenital rubella
Pathophysiology: Aorta → Pulmonary artery (L→R) → increased pulmonary blood flow and pressure
Clinical features:
  • Continuous "machinery murmur" at left infraclavicular area (Gibson's murmur)
  • Bounding pulse, wide pulse pressure
  • Tachypnea, failure to thrive in large PDA
Diagnosis: Echo (color Doppler), CXR (cardiomegaly, pulmonary plethora)
Treatment:
  • Premature neonates: Indomethacin (COX inhibitor, blocks prostaglandins that keep ductus open) or Ibuprofen; Acetaminophen as alternative
  • Term infants/children: Transcatheter coil/device occlusion or surgical ligation
  • Prostaglandin E1 (PGE1): Used to KEEP ductus OPEN in duct-dependent cyanotic CHD (e.g., TGA, pulmonary atresia) as bridge to surgery

D. TETRALOGY OF FALLOT (TOF) - Most Common CYANOTIC CHD (5%)

Four components (PROVE mnemonic):
  1. Pulmonary stenosis (infundibular - most important; determines severity)
  2. Right ventricular hypertrophy
  3. Overiding aorta (straddles VSD)
  4. VSD (large, perimembranous)
Pathophysiology: Pulmonary stenosis obstructs RV outflow → blood preferentially flows R→L through VSD → cyanosis
Clinical features:
  • Cyanosis (from birth or shortly after)
  • Hypercyanotic ("tet") spells - sudden worsening cyanosis, irritability, syncope, posturing; precipitated by crying, feeding, fever, exertion
  • Squatting posture - increases systemic vascular resistance → reduces R→L shunt (classic in older children)
  • Clubbing (with longstanding cyanosis)
  • Single S2
  • Ejection systolic murmur (due to pulmonary stenosis)
  • Boot-shaped heart on CXR ("coeur en sabot") - due to RVH elevating apex + concave pulmonary bay
  • Right aortic arch in 25%
Management of Tet spell (immediate):
  1. Knee-chest position (squatting equivalent)
  2. Supplemental O2
  3. Morphine (reduces infundibular spasm, calms patient)
  4. IV fluids (increase preload)
  5. Beta-blocker (propranolol) - reduces infundibular spasm
  6. Phenylephrine (alpha agonist - increases SVR)
  7. Sodium bicarbonate (for acidosis)
Definitive treatment: Surgical - complete repair (VSD patch + relief of RVOT obstruction). Palliative: Blalock-Taussig (BT) shunt - subclavian to pulmonary artery anastomosis to increase pulmonary blood flow

E. TRANSPOSITION OF GREAT ARTERIES (TGA) - 4%

  • Aorta arises from RV; pulmonary artery from LV
  • Two parallel circuits (not in series) - incompatible with life unless mixing occurs
  • Mixing via PFO, ASD, VSD, or PDA
  • Most common cyanotic CHD presenting in neonates
Clinical: Cyanosis from birth, no murmur in simple TGA, egg-on-side/egg-on-string appearance on CXR
Emergency management: PGE1 (to maintain PDA) + balloon atrial septostomy (Rashkind procedure) to improve mixing
Definitive surgery: Arterial switch operation (Jatene procedure) - performed in first 2 weeks of life (before LV depressurizes)

F. COARCTATION OF AORTA - 5%

Two forms:
  • Preductal (infantile): Proximal to PDA - associated with PDA, presents with cyanosis of lower body in neonates; rapidly fatal without treatment
  • Postductal (adult): Adjacent to ligamentum arteriosum - presents later in life
Classic signs (postductal):
  • Upper limb hypertension + lower limb hypotension/weak pulses (radiofemoral delay)
  • Systolic murmur
  • Rib notching on CXR (from enlarged intercostal collaterals)
  • "Figure 3" sign on CXR (indentation of aorta + dilated post-stenotic segment)
  • Associated with bicuspid aortic valve (>50%), berry aneurysms (Circle of Willis)
  • Common in Turner syndrome (45,XO)
Treatment: Balloon angioplasty/stenting or surgical resection with end-to-end anastomosis
  • Robbins & Kumar Basic Pathology, p. 350-351

6. DIAGNOSTIC APPROACH

Step 1: History

  • Age of presentation, cyanosis (central vs. peripheral)
  • Feeding difficulty, failure to thrive, recurrent chest infections
  • Maternal history (rubella, diabetes, drugs)
  • Family history

Step 2: Clinical Examination

  • Cyanosis (central - tongue/mucosa), clubbing, polycythemia
  • Growth parameters
  • Precordial bulge, apical impulse, heaves/thrills
  • Heart sounds: S2 splitting pattern
  • Murmur: systolic vs. diastolic vs. continuous; grading; radiation

Step 3: Investigations

InvestigationKey Findings
CXRBoot-shaped (TOF), Egg-on-side (TGA), Figure-3 sign (Coarc), Pulmonary plethora (L→R shunts), Snowman sign (TAPVC)
ECGRVH, LVH, axis deviation, RBBB (ASD), PR prolongation (AVSD)
EchocardiographyGold standard - 2D + color Doppler defines anatomy, shunt direction, gradient
Cardiac catheterizationQp:Qs ratio, pulmonary vascular resistance (>12 Wood units = inoperable), anatomy for surgery
MRI/CTComplex anatomy, aortic arch abnormalities
Pulse oximetryUniversal newborn screening tool
Hyperoxia test (Nitrogen washover)PaO2 <150 mmHg on 100% O2 suggests cyanotic CHD

7. MANAGEMENT PRINCIPLES

General Principles

  1. Anti-failure treatment before surgery (diuretics, digoxin, ACE inhibitors)
  2. Endocarditis prophylaxis (for unrepaired and recently repaired defects)
  3. PGE1 to maintain ductal patency in duct-dependent lesions
  4. Indomethacin to close PDA in premature neonates
  5. Timing of surgery based on physiology, not just anatomy

Surgical Options

  • Open-heart surgery with cardiopulmonary bypass (CPB)
  • Palliative (e.g., BT shunt for TOF, pulmonary artery banding for VSD)
  • Corrective/Definitive repair
  • Catheter-based interventions (device closure of ASD/VSD/PDA, balloon valvuloplasty, stenting)
  • Heart transplantation for complex unrepairable lesions (hypoplastic left heart syndrome)

Eisenmenger Syndrome

  • End-stage complication of large L→R shunts
  • Irreversible pulmonary hypertension with R→L shunt reversal
  • Late cyanosis, erythrocytosis, clubbing
  • Surgical repair is contraindicated
  • Management: Pulmonary vasodilators (bosentan, sildenafil), supportive care, transplantation

8. COMPLICATIONS

ComplicationDetails
Infective endocarditisRisk in VSD, PDA, bicuspid aortic valve
Pulmonary hypertensionEisenmenger syndrome
ArrhythmiasPost-surgical, especially after ASD/VSD repair
Brain abscessCyanotic CHD (paradoxical embolism, R→L shunt)
Polycythemia/hyperviscosityCyanotic CHD
Paradoxical emboli/strokeASD, PFO
Failure to thriveLarge shunts, recurrent infections
Sudden cardiac deathAortic stenosis, HCM, long QT

9. PROGNOSIS & OUTCOMES

  • With advances in surgery, >85% of children with CHD survive to adulthood
  • 1.5 million individuals currently living with CHD in the USA
  • 25% require surgical intervention in the first year of life
  • Operative mortality for most repairs: <2-4% in experienced centers
  • Long-term follow-up is essential for arrhythmias, residual lesions, and re-interventions

SUMMARY TABLE - Quick Exam Reference

DefectTypeKey SignCXRMurmurTreatment
VSDAcyanoticPansystolic LSBCardiomegaly, plethoraPansystolicPatch closure
ASDAcyanoticFixed S2 splitRA/RV enlargementESM pulmonaryDevice/surgical
PDAAcyanoticBounding pulseCardiomegalyContinuous machineryIndomethacin/ligation
PSAcyanoticEjection clickBoot-likeESM upper LSBBalloon valvuloplasty
CoarctationAcyanoticRadio-femoral delayRib notching, Fig 3Systolic backSurgery/stenting
TOFCyanoticSquattingBoot-shaped heartESMBT shunt → Complete repair
TGACyanoticNeonatal cyanosisEgg-on-sideNone/softPGE1 → Jatene op

Sources: Robbins & Kumar Basic Pathology (9e), Schwartz's Principles of Surgery (11e), Braunwald's Heart Disease, Goldman-Cecil Medicine - integrated with standard pediatric cardiology knowledge (Nelson's Textbook of Pediatrics principles)
This is a shared conversation. Sign in to Orris to start your own chat.